ALMS Company Profile and Key Details

NASDAQ : ALMS

Alumis

$25.37

-2.16-7.85%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Alumis Inc. (ALMS) stock declined over -7.85%, trading at $25.37 on NASDAQ, down from the previous close of $27.53. The stock opened at $27.68, fluctuating between $23.81 and $27.69 in the recent session.

Stock Snapshot

27.53

Prev. Close

3.13B

Market Cap

23.81

Day Low

-6.47

P/E Ratio

-3.92

EPS (TTM)

N/A

Cash Flow per Share

27.68

Open

123.43M

Number of Shares

27.69

Day High

68.27%

Free Float in %

N/A

Book Value

1.32M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 11, 2026	27.68	27.69	23.80	25.37	1.32M
Aug 10, 2026	27.36	27.94	27.00	27.53	456.22K
Aug 07, 2026	28.00	28.17	26.84	27.60	782.71K
Aug 06, 2026	27.10	28.56	27.10	27.80	653.45K
Aug 05, 2026	27.24	27.94	26.70	27.12	629.13K
Aug 04, 2026	26.35	27.38	26.18	27.12	753.85K
Aug 03, 2026	27.69	27.70	25.29	26.12	1.39M
Jul 31, 2026	28.95	29.20	27.57	28.25	1.32M
Jul 30, 2026	26.95	29.15	26.79	28.95	991.96K
Jul 29, 2026	27.16	27.45	25.80	26.38	819.91K
Jul 28, 2026	27.37	27.37	26.06	27.03	780.17K
Jul 27, 2026	27.79	29.28	26.72	27.08	1.05M
Jul 24, 2026	28.48	28.51	26.94	28.00	1.16M
Jul 23, 2026	28.24	28.60	27.69	28.30	649.99K
Jul 22, 2026	29.55	29.60	28.28	28.81	812.99K
Jul 21, 2026	28.16	30.11	28.12	30.05	874.56K
Jul 20, 2026	28.55	29.57	27.92	27.98	694.5K
Jul 17, 2026	26.87	28.97	26.58	28.66	1M
Jul 16, 2026	28.75	28.76	26.85	27.23	1.28M
Jul 15, 2026	26.92	28.90	26.15	28.81	1.49M

Contact Details

South San Francisco, CA 94080

United States

https://www.alumis.com 650 231 6625

About Company

Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory and neurodegenerative diseases. It also develops lonigutamab, a monoclonal antibody targeting IGF-1R for the treatment of thyroid eye diseases; and interferon regulatory factor 5 (IRF5) to address immune dysfunction. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. Alumis Inc. was incorporated in 2021 and is headquartered in South San Francisco, California.

Stock Peers

ARGX

-1.37-0.16%

argenx SE$864.74 REGN

-11.05-1.37%

Regeneron Pharmaceuticals, Inc.$797.00 MDGL

19.93+3.87%

Madrigal Pharmaceuticals, Inc.$535.27 VRTX

5.74+1.10%

Vertex Pharmaceuticals Incorporated$529.65 UTHR

-14.16-2.67%

United Therapeutics Corporation$515.50 PRAX

3.72+1.01%

Praxis Precision Medicines, Inc.$370.68 ONC

0.27+0.08%

BeOne Medicines AG$359.27 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 KRYS

-4.54-1.37%

Krystal Biotech, Inc.$327.05 LGND

-6.95-2.35%

Ligand Pharmaceuticals Incorporated$288.75

Frequently Asked Questions

What is the current Alumis Inc. (ALMS) stock price?

Alumis Inc. (NASDAQ: ALMS) stock price is $25.37 in the last trading session. During the trading session, ALMS stock reached the peak price of $27.69 while $23.81 was the lowest point it dropped to. The percentage change in ALMS stock occurred in the recent session was -7.85% while the dollar amount for the price change in ALMS stock was - $2.16.

ALMS's industry and sector of operation?

The NASDAQ listed ALMS is part of Biotechnology industry that operates in the broader Healthcare sector. Alumis Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ALMS?

No Data

How ALMS did perform over past 52-week?

ALMS's closing price is 574.73% higher than its 52-week low of $3.76 where as its distance from 52-week high of $31.35 is -19.07%.

How many employees does ALMS have?

Number of ALMS employees currently stands at 224.

Link for ALMS official website?

Official Website of ALMS is: https://www.alumis.com

How do I contact ALMS?

ALMS could be contacted at phone 650 231 6625 and can also be accessed through its website. ALMS operates from 280 East Grand Avenue, South San Francisco, CA 94080, United States.

How many shares of ALMS are traded daily?

ALMS stock volume for the day was 1.32M shares. The average number of ALMS shares traded daily for last 3 months was 1.29M.

What is the market cap of ALMS currently?

The market value of ALMS currently stands at $3.13B with its latest stock price at $25.37 and 123.43M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	224
Beta	-0.71
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

Employees	224
Beta	-0.71
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

ALMS Company Profile and Key Details

Alumis

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Shareholding & Insider Activity

Dividend & Fair Value

Company Overview

Earnings & Analyst Outlook

Valuation Metrics

Key Takeaways

Price Forecast & Outlook